Surgical treatment experience for patients with stage I-III esophageal cancer
Today, esophageal cancer (EC) remains a complex oncological problem. Aim of the work is to assess the survival rates of patients with the I–III stages esophageal cancer and esophagogastric junction. Materials and methods. 50 patients with the I-III stages EC and esophagogastric junction cancer...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2018-06-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/130822/131028 |
_version_ | 1811251225220349952 |
---|---|
author | О. P. Kolesnik I. P. Kolesnyk V. V. Kechedzhyiev |
author_facet | О. P. Kolesnik I. P. Kolesnyk V. V. Kechedzhyiev |
author_sort | О. P. Kolesnik |
collection | DOAJ |
description | Today, esophageal cancer (EC) remains a complex oncological problem.
Aim of the work is to assess the survival rates of patients with the I–III stages esophageal cancer and esophagogastric junction.
Materials and methods. 50 patients with the I-III stages EC and esophagogastric junction cancer were operated in the Thoracic Surgery Department of Municipal Institution “Zaporizhzhia Regional Clinical Oncology Dispensary” for the period from 2010 to 2017. The Ivor–Lewis surgery was an operation of choice.
Results. While survival analysis it was noted that the 5-year overall survival rate among operated patients was 40.3 %, median survival made 21.0 months. In the patients with the I–II stages median survival time wasn't reached (more than 50.0 % of patients survived a 5-year follow-up period) and the 5-year overall survival rate made 50.9 % (P < 0.05), while in patients with the III stage median survival time made 13.0 months (P < 0.05).
Conclusions. The results of the surgical treatment of patients with EC and esophagogastric junction of the I–III stages in the Thoracic Surgery Department of Municipal Institution “Zaporizhzhia Regional Clinical Oncology Dispensary” did not differ from the overall results of this issue studies. At the same time acceptable indications of postoperative complications, mortality and overall survival have been reached. |
first_indexed | 2024-04-12T16:16:30Z |
format | Article |
id | doaj.art-6a701ac5cc0746d3a67ed235e4a82863 |
institution | Directory Open Access Journal |
issn | 2306-4145 2310-1210 |
language | English |
last_indexed | 2024-04-12T16:16:30Z |
publishDate | 2018-06-01 |
publisher | Zaporozhye State Medical University |
record_format | Article |
series | Zaporožskij Medicinskij Žurnal |
spelling | doaj.art-6a701ac5cc0746d3a67ed235e4a828632022-12-22T03:25:42ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102018-06-01344845310.14739/2310-1210.2018.3.130822Surgical treatment experience for patients with stage I-III esophageal cancerО. P. Kolesnik I. P. KolesnykV. V. KechedzhyievToday, esophageal cancer (EC) remains a complex oncological problem. Aim of the work is to assess the survival rates of patients with the I–III stages esophageal cancer and esophagogastric junction. Materials and methods. 50 patients with the I-III stages EC and esophagogastric junction cancer were operated in the Thoracic Surgery Department of Municipal Institution “Zaporizhzhia Regional Clinical Oncology Dispensary” for the period from 2010 to 2017. The Ivor–Lewis surgery was an operation of choice. Results. While survival analysis it was noted that the 5-year overall survival rate among operated patients was 40.3 %, median survival made 21.0 months. In the patients with the I–II stages median survival time wasn't reached (more than 50.0 % of patients survived a 5-year follow-up period) and the 5-year overall survival rate made 50.9 % (P < 0.05), while in patients with the III stage median survival time made 13.0 months (P < 0.05). Conclusions. The results of the surgical treatment of patients with EC and esophagogastric junction of the I–III stages in the Thoracic Surgery Department of Municipal Institution “Zaporizhzhia Regional Clinical Oncology Dispensary” did not differ from the overall results of this issue studies. At the same time acceptable indications of postoperative complications, mortality and overall survival have been reached.http://zmj.zsmu.edu.ua/article/view/130822/131028esophageal canceroperative surgical procedureslymph node excisionsurvival |
spellingShingle | О. P. Kolesnik I. P. Kolesnyk V. V. Kechedzhyiev Surgical treatment experience for patients with stage I-III esophageal cancer Zaporožskij Medicinskij Žurnal esophageal cancer operative surgical procedures lymph node excision survival |
title | Surgical treatment experience for patients with stage I-III esophageal cancer |
title_full | Surgical treatment experience for patients with stage I-III esophageal cancer |
title_fullStr | Surgical treatment experience for patients with stage I-III esophageal cancer |
title_full_unstemmed | Surgical treatment experience for patients with stage I-III esophageal cancer |
title_short | Surgical treatment experience for patients with stage I-III esophageal cancer |
title_sort | surgical treatment experience for patients with stage i iii esophageal cancer |
topic | esophageal cancer operative surgical procedures lymph node excision survival |
url | http://zmj.zsmu.edu.ua/article/view/130822/131028 |
work_keys_str_mv | AT opkolesnik surgicaltreatmentexperienceforpatientswithstageiiiiesophagealcancer AT ipkolesnyk surgicaltreatmentexperienceforpatientswithstageiiiiesophagealcancer AT vvkechedzhyiev surgicaltreatmentexperienceforpatientswithstageiiiiesophagealcancer |